Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-20,000
Closed -$946K 739
2017
Q4
$946K Hold
20,000
0.01% 418
2017
Q3
$966K Hold
20,000
0.01% 404
2017
Q2
$1M Hold
20,000
0.02% 371
2017
Q1
$892K Hold
20,000
0.02% 413
2016
Q4
$769K Hold
20,000
0.01% 488
2016
Q3
$785K Sell
20,000
-11,300
-36% -$460K 0.01% 461
2016
Q2
$1.28M Sell
31,300
-8,700
-22% -$347K 0.03% 350
2016
Q1
$1.64M Buy
40,000
+26,200
+190% +$970K 0.04% 274
2015
Q4
$504K Sell
13,800
-40,000
-74% -$1.53M 0.01% 566
2015
Q3
$1.94M Buy
+53,800
New +$2.07M 0.04% 261

Other funds holding ORCL

Scotia Capital's ORCL Position: Q1 2026 in Review

Scotia Capital reduced its Oracle (ORCL) stake by 0.04% in Q1 2026, selling an estimated $21.3K and leaving 356,344 shares worth $52.4M. The position accounts for 0.22% of the portfolio, ranked #75.

Scotia Capital first reported a position in ORCL in Q2 2013 and has held it in 52 quarters since. The position peaked at $85.9M in Q3 2025. 3,472 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Scotia Capital held 356,344 shares of Oracle worth $52.4M as of Q1 2026.
  • Scotia Capital sold 131 Oracle shares in Q1 2026, an estimated $21.3K.
  • Oracle made up 0.22% of Scotia Capital's portfolio in Q1 2026, its #75 holding.
  • Scotia Capital first reported a position in Oracle in Q2 2013 and has held it in 52 quarters since.
  • Scotia Capital's Oracle position peaked at $85.9M in Q3 2025.
  • 3,472 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.